Table 2 Details of the three groups, each with alternative dose and fractionation schedules, employed in this study
Group I (n = 20) | Group II (n = 20) | Group III (n = 20) | |
|---|---|---|---|
Total Dose | 65 Gy/30 fractions | 73 Gy/30 Fractions | 82 Gy/30 Fractions |
EQD2 Gyα/β=10 | 65.92 Gy10 | 75.82 Gy10 | 87.82 Gy10 |
Target volume | Dose/fraction (Gy) | Fractions | Dose/fraction (Gy) | Fractions | Dose/fraction (Gy) | Fractions | |
|---|---|---|---|---|---|---|---|
PTV65 | Plan 1 | 2.17 | 1–15 | 2.17 | 1–15 | 2.17 | 1–15 |
GTV | 2.17 | 1–15 | 2.17 | 1–15 | 2.17 | 1–15 |
Total dose | 32.5 Gy/15 fractions | 32.5 Gy/15 fractions | 32.5 Gy/15 fractions | ||||
|---|---|---|---|---|---|---|---|
PTV65 | Plan 2 | 2.17 | 16–30 | 2.17 | 16–30 | 2.17 | 16–30 |
GTV | 2.17 | 16–30 | 2.70 | 16–30 | 3.30 | 16–30 | |